Natco Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 2,264.00 28.70  | 1.28% 125.33% 55.93 7,528.19
NSE Price: Jun 30, 13:39 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jun 30, 13:39 2,264.00 28.70 1.28% 2,253.95 2,235.30 85,912 2,232.05 - 2,280.00
BSE Jun 30, 13:43 2,261.40 36.50 1.64% 2,240.00 2,224.90 12,208 2,233.30 - 2,279.95
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 162,101 P/B: 8.90 NSE Code: NATCOPHARM
52-Week Range: R 971.25 - 2,709.85 Dividend Yield: 0.22% BSE Code: 524816
TTM EPS: R 40.50 Book Value: R 254.57 Face Value: R 10
Price Graph
  • Glenmark Pharma. (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Natco Pharma 46.07 0.99 5.81 127.50 87.83 61.42 34.26
S&P BSE Mid Cap 1.62 -1.64 1.74 14.50 19.65 8.17 12.29
S&P BSE Healthcare 10.41 -4.01 -4.31 44.07 33.07 23.11 19.28
Company's return has been calculated on basis of NSE's price.
As on Jun 29, 2015
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 11.86 17.14 10.75
Net Profit 48.91 23.64 16.69
EPS 35.60 17.78 14.65
Book Value 29.06 20.57 19.03
Average
Operating Margin 26.53 24.58 23.09
Net Margin 12.98 11.25 11.06
Return on Networth 15.58 14.27 15.12
Return on Investment 18.02 16.60 16.90
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.73 9.25 9.25
Operating Profit -4.08 11.52 11.52
Net Profit 289.09 108.51 108.51
EPS 279.64 125.55 125.55
TTM
Revenue 2.10 11.71 11.71
Operating Profit 2.44 16.44 16.44
Net Profit 26.96 32.96 32.96
EPS 28.96 459.03 459.03
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Natco Pharma 7,528.19 825.45 130.26 15.49 15.58 8.90 55.93
Divi's Laboratories 24,571.11 3,084.01 847.06 26.84 28.31 7.03 28.86
Glenmark Pharma. 28,057.61 6,644.77 475.24 7.14 18.99 7.11 59.03
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Apr 06, 2015 B R Reddy  Sell ESOP 2,000 2,428.15 48.56
Apr 06, 2015 M Srikanth  Sell ESOP 1,000 2,428.15 24.28
Oct 13, 2014 Linga Rao Donthineni  Sell Market 2,500 1,393.55 34.84
Jun 30, 2014 NATCO Group Employees Welfare Trust  Sell Off Market 8,846 1,004.75 88.88
Jun 19, 2014 Neelima Nannapaneni Trust  Buy Market 360,000 1,031.95 3,715.02
Fund Houses invested in the stock
Fund Mar-15 Dec-14 Sep-14 Jun-14 Mar-14
ICICI Prudential Mutual Fund 2.592 3.326 3.443 - -
SBI Mutual Fund 1.129 1.978 0.759 2.120 2.701
Mirae Asset Mutual Fund 0.451 0.424 0.388 0.115 -
L&T Mutual Fund 0.416 0.575 0.759 0.854 0.932
UTI Mutual Fund 0.407 0.392 0.372 0.393 0.254
Sahara Mutual Fund 0.003 0.005 0.006 - -
Shriram Mutual Fund 0.003 0.003 0.004 0.002 0.004
Birla Sun Life Mutual Fund NA 0.624 0.670 0.660 -
Franklin Templeton Mutual Fund NA 0.122 0.228 0.228 0.183
Edelweiss Mutual Fund NA 0.008 - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Natco Pharma Ltd.

Address: Natco House, Road No 2, Banjara Hills, Hyderabad, Andhra Pradesh - 500033 | Phone: +91-40- 23547532 | Fax: +91-40- 23548243

Email: investors@natcophrma.co.in

Website: www.natcopharma.co.in

Registrar & Transfer Agent: Venture Capital & Corporate Investments Ltd

Address: 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad | Phone: 91-40-23818475/6 | Fax: 91-40-23868024

Email: info@vccilindia.com

Related Stocks
Natco Pharma ₹2,264.00 +1.28%
Ajanta Pharma ₹1,555.75 +2.05%
Biocon ₹460.00 -0.67%
Divi's Laboratories ₹1,849.70 +0.91%
Glenmark Pharma. ₹993.55 +1.97%
Pfizer ₹1,999.00 +0.90%
Piramal Enterprises ₹933.00 +0.16%
Sun Pharma Adv. Research ₹392.60 +2.71%
Torrent Pharmaceuticals ₹1,303.05 +0.70%
Wockhardt ₹1,408.10 +1.90%
As on Jun 30, 13:40